Company Calyxt, Inc. Nasdaq
Equities
CBUS
US17166A1016
Advanced Medical Equipment & Technology
Business Summary
Number of employees: 183
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Other
100.0
%
| 0 | 0.2 % | 0 | 100.0 % | +175.44% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 26 | 100.0 % | 0 | 100.0 % | -99.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Wade King
DFI | Director of Finance/CFO | 67 | - |
Peter Beetham
PSD | President | 61 | - |
Greg Gocal
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Steve Berreth
LAW | General Counsel | - | 23-08-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Mark Finn
BRD | Director/Board Member | 81 | - |
Keith Walker
BRD | Director/Board Member | 76 | - |
Peter Beetham
PSD | President | 61 | - |
Gerhard Prante
BRD | Director/Board Member | 82 | - |
Jean Lehmann
BRD | Director/Board Member | 85 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,142,636 | 0 | 0 | 70.17 % |
Stock B | 1 | 22,145,053 | 15,538,984 ( 70.17 %) | 599,922 ( 2.709 %) |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+9.55% | 222B | |
+14.41% | 195B | |
+24.02% | 148B | |
+33.92% | 113B | |
+4.18% | 66.45B | |
+12.92% | 53.11B | |
+3.16% | 50.03B | |
-4.32% | 38.8B | |
-1.99% | 34.85B |